List of the 35 most frequent BCR-ABL1 kinase domain mutations associated with resistance to TKIs (based on the integration of in vitro IC50 data and in vivo observations)
Mutation . | TKI(s) to which the mutation confers resistance . |
---|---|
M244V | Imatinib |
L248V | Imatinib |
G250E | Imatinib |
Q252H | Imatinib |
Y253H | Imatinib, nilotinib |
E255V | Imatinib, nilotinib, bosutinib |
E255K | Imatinib, nilotinib, bosutinib |
L273M | Imatinib |
D276G | Imatinib |
T277A | Imatinib |
E279K | Imatinib |
V299L | Dasatinib, bosutinib |
F311L | Imatinib |
T315I | Imatinib, nilotinib, dasatinib, bosutinib |
T315A | Dasatinib |
T315M | Ponatinib |
T315L | Ponatinib |
F317L | Imatinib, dasatinib |
F317V | Imatinib, dasatinib |
F317I | Imatinib, dasatinib |
F317C | Imatinib, dasatinib |
M351T | Imatinib |
E355G | Imatinib |
F359C | Imatinib, nilotinib |
F359I | Imatinib, nilotinib |
F359V | Imatinib, nilotinib |
E379K | Imatinib |
L384M | Imatinib |
L387M | Imatinib |
L387F | Imatinib |
H396R | Imatinib |
H396P | Imatinib |
E459K | Imatinib |
F486S | Imatinib |
Mutation . | TKI(s) to which the mutation confers resistance . |
---|---|
M244V | Imatinib |
L248V | Imatinib |
G250E | Imatinib |
Q252H | Imatinib |
Y253H | Imatinib, nilotinib |
E255V | Imatinib, nilotinib, bosutinib |
E255K | Imatinib, nilotinib, bosutinib |
L273M | Imatinib |
D276G | Imatinib |
T277A | Imatinib |
E279K | Imatinib |
V299L | Dasatinib, bosutinib |
F311L | Imatinib |
T315I | Imatinib, nilotinib, dasatinib, bosutinib |
T315A | Dasatinib |
T315M | Ponatinib |
T315L | Ponatinib |
F317L | Imatinib, dasatinib |
F317V | Imatinib, dasatinib |
F317I | Imatinib, dasatinib |
F317C | Imatinib, dasatinib |
M351T | Imatinib |
E355G | Imatinib |
F359C | Imatinib, nilotinib |
F359I | Imatinib, nilotinib |
F359V | Imatinib, nilotinib |
E379K | Imatinib |
L384M | Imatinib |
L387M | Imatinib |
L387F | Imatinib |
H396R | Imatinib |
H396P | Imatinib |
E459K | Imatinib |
F486S | Imatinib |